-
EKOS Corporation addresses treatment for pulmonary embolism
- May 3, 2012
-
Settlement Master appointed over Fosamax litigation
- Dec 22, 2011
-
FDA advisory panel under scrutiny for voting against Yaz recall
- Mar 27, 2012
-
What a difference a day makes: Pradaxa v. Warfarin
- Jun 22, 2012
-
Pradaxa's bleeding concerns
- Jun 18, 2012
-
Three bellwether trials against Merck scheduled for 2012
- Dec 27, 2011
-
FDA issues warning after codeine kills children post-surgery
- Aug 16, 2012
-
Artificial retina gives sight to blind mice
- Aug 16, 2012
-
Lucentis approved for diabetic macular edema
- Aug 14, 2012
-
Mayo Clinic: Patients in the dark about prescriptions
- Aug 9, 2012
-
Hospital's plan to prevent painkiller abuse
- Aug 8, 2012
-
Alzheimer's drug disappoints
- Aug 8, 2012
Avandia statin metal-on-metal hip replacement listeria D.C. bladder cancer Johnson & Johnson Eliquis GlaxoSmithKline MenHibrix lawsuits diet drug Nexavar generic SSRI Actos TVM pulmonary embolism pulomonary embolism deep vein thrombosis liver damage Fosamax breast cancer FDA chemotherapy Inspiration Video Games Zimmer Tutorials Technology